Tinsley S, Chianis E, Shelley R, Mall G, Dhiman A, Baral G
Oncogene. 2024; 43(50):3673-3687.
PMID: 39443726
DOI: 10.1038/s41388-024-03196-w.
Tinsley S, Shelley R, Mall G, Chianis E, Dhiman A, Baral G
bioRxiv. 2024; .
PMID: 38826439
PMC: 11142131.
DOI: 10.1101/2023.07.01.547283.
Kelson C, Zaytseva Y
Front Oncol. 2024; 14:1343061.
PMID: 38590663
PMC: 10999677.
DOI: 10.3389/fonc.2024.1343061.
Anurag Anand A, Khan M, V M, Kar D
Int J Cell Biol. 2023; 2023:9296092.
PMID: 37780577
PMC: 10539095.
DOI: 10.1155/2023/9296092.
Zhang Q, Feng X, Zhang M, Sun W, Zhai Y, Qing S
BMC Genomics. 2023; 24(1):430.
PMID: 37528394
PMC: 10391883.
DOI: 10.1186/s12864-023-09481-4.
Feedback in the β-catenin destruction complex imparts bistability and cellular memory.
Cantoria M, Alizadeh E, Ravi J, Varghese R, Bunnag N, Pond K
Proc Natl Acad Sci U S A. 2023; 120(2):e2208787120.
PMID: 36598937
PMC: 9926258.
DOI: 10.1073/pnas.2208787120.
Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β.
Chen L, Wu L, Wang W, Zhai L, Xiang F, Li W
Int J Oncol. 2022; 61(4).
PMID: 35929518
PMC: 9387559.
DOI: 10.3892/ijo.2022.5406.
Growth arrest of PPP2R5C and PPP2R5D double knockout mice indicates a genetic interaction and conserved function for these PP2A B subunits.
Dyson J, Abbasi F, Varadkar P, McCright B
FASEB Bioadv. 2022; 4(4):273-282.
PMID: 35415460
PMC: 8984082.
DOI: 10.1096/fba.2021-00130.
A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth.
Papke C, Smolen K, Swingle M, Cressey L, Heng R, Toporsian M
J Biol Chem. 2021; 296:100313.
PMID: 33482199
PMC: 7952134.
DOI: 10.1016/j.jbc.2021.100313.
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.
Xu X, Zhang M, Xu F, Jiang S
Mol Cancer. 2020; 19(1):165.
PMID: 33234169
PMC: 7686704.
DOI: 10.1186/s12943-020-01276-5.
Burden of rare deleterious variants in WNT signaling genes among 511 myelomeningocele patients.
Hebert L, Hillman P, Baker C, Brown M, Ashley-Koch A, Hixson J
PLoS One. 2020; 15(9):e0239083.
PMID: 32970752
PMC: 7514064.
DOI: 10.1371/journal.pone.0239083.
Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects.
El-Saber Batiha G, Alqahtani A, Ilesanmi O, Saati A, El-Mleeh A, Hetta H
Pharmaceuticals (Basel). 2020; 13(8).
PMID: 32824399
PMC: 7464486.
DOI: 10.3390/ph13080196.
Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.
Li M, Fan L, Han D, Yu Z, Ma J, Liu Y
J Clin Invest. 2020; 130(8):4301-4319.
PMID: 32396532
PMC: 7410060.
DOI: 10.1172/JCI134930.
The PRR14 heterochromatin tether encodes modular domains that mediate and regulate nuclear lamina targeting.
Dunlevy K, Medvedeva V, Wilson J, Hoque M, Pellegrin T, Maynard A
J Cell Sci. 2020; 133(10).
PMID: 32317397
PMC: 7272351.
DOI: 10.1242/jcs.240416.
Insight into unique somitogenesis of yak (Bos grunniens) with one additional thoracic vertebra.
Wang Y, Cai H, Luo X, Ai Y, Jiang M, Wen Y
BMC Genomics. 2020; 21(1):201.
PMID: 32131721
PMC: 7057515.
DOI: 10.1186/s12864-020-6598-9.
Protein Phosphatase 2A: More Than a Passenger in the Regulation of Epithelial Cell-Cell Junctions.
Schuhmacher D, Sontag J, Sontag E
Front Cell Dev Biol. 2019; 7:30.
PMID: 30895176
PMC: 6414416.
DOI: 10.3389/fcell.2019.00030.
Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate.
Pedone E, Marucci L
Genes (Basel). 2019; 10(2).
PMID: 30823613
PMC: 6410200.
DOI: 10.3390/genes10020176.
Striatin is a novel modulator of cell adhesion.
Lahav-Ariel L, Caspi M, Nadar-Ponniah P, Zelikson N, Hofmann I, Hanson K
FASEB J. 2018; 33(4):4729-4740.
PMID: 30592649
PMC: 6988865.
DOI: 10.1096/fj.201801882R.
Benzene-induced mouse hematotoxicity is regulated by a protein phosphatase 2A complex that stimulates transcription of .
Chen L, Guo P, Zhang H, Li W, Gao C, Huang Z
J Biol Chem. 2018; 294(7):2486-2499.
PMID: 30567741
PMC: 6378973.
DOI: 10.1074/jbc.RA118.006319.
Characterization of a effector uncovers an alternative GSK3/β-catenin-regulatory pathway of inflammation.
He H, Brenier-Pinchart M, Braun L, Kraut A, Touquet B, Coute Y
Elife. 2018; 7.
PMID: 30320549
PMC: 6214654.
DOI: 10.7554/eLife.39887.